IL2 and melanoma: This T cell effect demonstrates epitope spread, as ch14.18-IL2 enables C57Bl/6 mice to destroy GD2− B16 melanoma cells, but only if they are a component of mixed tumors, created by co-injection with the GD2+ B78 melanoma cells (Table 1) [55].